Patent details

EP3512860 Title: NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT

Basic Information

Publication number:
EP3512860
PCT Application Number:
CA2017051095
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP178499752
PCT Publication Number:
WO2018049534
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT
French Title of Invention:
ANALOGUES DE NUCLÉOSIDES ET DE NUCLÉOTIDES PORTANT UN CENTRE STÉRÉOGÈNE TOUT CARBONE QUATERNAIRE EN POSITION 2' ET PROCÉDÉS D'UTILISATION EN TANT QU'AGENT CARDIOPROTECTEUR
German Title of Invention:
NUKLEOSID- UND NUKLEOTID-ANALOGA MIT EINEM QUARTÄREN STEREOGENEN ZENTRUM AUS KOHLENSTOFF AN DER 2'-POSITION UND VERFAHREN ZUR VERWENDUNG ALS KARDIOPROTEKTIVES MITTEL
SPC Number:

Dates

Filing date:
18/09/2017
Grant date:
25/11/2020
EP Publication Date:
24/07/2019
PCT Publication Date:
22/03/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/11/2020
EP B1 Publication Date:
25/11/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/09/2021
Expiration date:
18/09/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/11/2020
 
 

Name:
LCB Pharma Inc.
Address:
12230 Avenue Lemesurier, Montréal, Québec H4K 2B3, Canada (CA)

Name:
Université D'Ottawa
Address:
800 King Edward, 3042 VRTT, Ottawa, Ontario K1N 6N5, Canada (CA)

Inventor

1

Name:
NEMER, Mona
Address:
Canada (CA)

2

Name:
GUINDON, Yvan
Address:
Canada (CA)

3

Name:
MOCHIRIAN, Philippe
Address:
Canada (CA)

Priority

1

Priority Number:
201662395430 P
Priority Date:
16/09/2016
Priority Country:
United States (US)

2

Priority Number:
201662395411 P
Priority Date:
16/09/2016
Priority Country:
United States (US)

3

Priority Number:
201662395401 P
Priority Date:
16/09/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/7076; A61P 9/00; C07H 19/06; C07H 19/10; C07H 19/12; C07H 19/20; C07H 19/23;

Publication

European Patent Bulletin

Issue number:
202048
Publication date:
25/11/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages